-

Kinos Medical Merges with restor3d

DURHAM, N.C.--(BUSINESS WIRE)--restor3d is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.

restor3d (Durham, NC), a leader in patient-specific 3D printed implants, is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company. restor3d (Durham, NC), was founded with a mission to enable surgeons to repair and reconstruct the human body using 3D printing technologies, advanced biomaterials, and artificial intelligence. In 2018, the company invested in significant infrastructure and in-house manufacturing capabilities to expand its offering of implants in orthopedic and spine indications. With a robust pipeline of products slated for regulatory submission, recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos Medical (Wayne, PA) will accelerate restor3d’s expansion into the high-growth foot and ankle market in the U.S.

Kinos was founded in 2017 to translate and commercialize Coulter Foundation funded biomechanics research, led by professor Sorin Siegler, Ph.D. Together as an interdisciplinary team of clinical thought leaders, engineers, scientists, and investors, “Kinos is focused on improving the surgical options available to preserve motion in patients with ankle arthritis. The Axiom total ankle is the first biomechanically accurate implant on the market, offering motion in all three anatomic planes, as is seen in the natural ankle,” said Brian Garvey, CEO of Kinos Medical. “We are thrilled to partner with the restor3d team to combine our advanced technologies into a holistic product offering.”

restor3d and Kinos share an uncommon, persistent dedication to science and technology in the pursuit of improving patients’ outcomes and healthcare, and I am very excited to have found peers in arthroplasty whose products reflect this,” said Andy Miller Ph.D., co-founder and CEO of restor3d. By merging the two companies, we will be able to apply our technologies to provide advanced solutions in new device applications that are outside restor3d’s current scope, first in foot and ankle, and then followed by other areas of medicine. The unique combination of expertise between restor3d and Kinos will lead to products that are truly at the leading edge.”

Ken Gall Ph.D., a Professor at Duke University and co-founder of restor3d adds, “My belief is that surgical reconstructions of the future will be performed with implants that are tuned to the anatomy, biomechanics, and tissue biology of individual patients and explicitly designed and improved based on data sets of pre- and post- operative clinical data. The combination of these two thriving businesses is an exciting step towards this future.”

The Kinos portfolio mirrors the vision of Restor3d, where pre-operative planning, superior implant design and intraoperative guidance is seamlessly tailored to the individual needs of the patient and surgeon.

About restor3d:

restor3d enables surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. Leveraging expertise and experience in 3D printing of key biomedical materials spanning a wide range of properties, restor3d seeks to improve medical device solutions.

For more information, visit: http://www.restor3d.com.

Contacts

Lisa Marie Del Re, MPE, ATC, NASM-PES
restor3d
208.724.7786
lisamarie@restor3d.com

restor3d


Release Summary
restor3d, a leader in patient-specific 3D printed implants, announces exciting merger with Kinos Medical, a leading total ankle replacement company.
Release Versions

Contacts

Lisa Marie Del Re, MPE, ATC, NASM-PES
restor3d
208.724.7786
lisamarie@restor3d.com

Social Media Profiles
More News From restor3d

restor3d Secures $38 Million in Growth Capital to Drive Expansion and Innovation in Personalized Orthopedic Solutions

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D printed, personalized orthopedic implant care, announced today the successful completion of capital raising efforts totaling $38 million. These funding rounds included participation from both existing and new private investors, including Summers Value Partners. The investments will fuel the company’s continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. “From the beginning, our mission at restor3...

Title restor3d receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic implant care, has received FDA 510(k) clearance for the iTotal Identity™ CR 3DP Porous Total Knee Replacement System. This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in Q3 of 2025. The Identity 3...

restor3d Announces FDA Clearance of Ossera™ AFX Ankle Fusion System, Showcasing Innovations at ACFAS 2025

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic implant care, will showcase its latest foot and ankle innovations at the American College of Foot & Ankle Surgery (ACFAS) Annual Meeting in Phoenix, Ariz., from March 27-30, 2025. Among the highlights is the newly FDA 510(k)-cleared Ossera™ AFX Ankle Fusion System, engineered to advance fusion procedures through cutting-edge 3D printing and TIDAL Technology™. "We understand that every surgeon has unique...
Back to Newsroom